Editors are searching for diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests, and so on. Candidates should have, but not limited to, 12 years or fewer experience in healthcare.
Are you or someone you know an up-and-coming or “emerging” leader in the healthcare industry?
Fill out a nominee form for a chance to be chosen as one of the winners in Managed Healthcare Executive’s annual Emerging Leaders in Healthcare feature.
The popular human-interest story features healthcare leaders paving the way for the future of their organizations, for healthcare and for others seeking to make a difference in the industry.
MHE has featured a number of game-changers in the past. Some can be found in last year’s issue here and the 2021 version here.
This year’s issue is planned to make its way back to readers in MHE’s September edition.
Editors are searching for a diverse group of healthcare professionals coming from different backgrounds, healthcare sectors, with different interests and so on. Candidates should have, but not limited to, 12 years or fewer experience in healthcare.
To be considered a candidate, those interested must fill out the nominee form accessible here.
After a thorough selection process, editors will select the winners and have them fill out a short questionnaire and sit for a brief video interview.
Email nominee forms to Managing Editor Peter Wehrwein and to Editor Briana Contreras by June 16.
Good luck!
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
New approvals this week include a $4.25 million gene therapy, a drug that treats hypertension in a new way, a nonsteroidal drug for Duchenne, and an oral drug for aggressive leukemia. The agency has set an action date for resubmitted Lymphir in rare skin cancer, and Celltrion has launched Zymfentra, a subcutaneous form of infliximab.
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen